The Use of Recombinant Human Bone Morphogenetic Protein-2 in Revision Reverse Shoulder Arthroplasty with Glenoid Bone Loss on Secondary Revision Surgery Rates with Minimum 2-Year Follow-Up

Journal of Shoulder and Elbow Arthroplasty · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles